Ionis Pharmaceuticals, Inc.
Modulation of Lnc05 expression
Last updated:
Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of Inc05 in a cell or individual. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a cancer in an individual.
Status:
Grant
Type:
Utility
Filling date:
1 Dec 2017
Issue date:
15 Jun 2021